HAWAII MINORITY-BASED CCOP

夏威夷少数民族 CCOP

• 批准号: 6512931
• 负责人: BRIAN F ISSELL
• 金额: $ 50.46万
• 依托单位: UNIVERSITY OF HAWAII AT MANOA
• 依托单位国家: 美国
• 财政年份: 1994
• 资助国家: 美国
• 起止时间: 1994-08-01 至 2005-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6512931
• 关键词: Asians; Hawaii; cancer prevention; cancer rehabilitation /care; cancer risk; clinical research; clinical trials; community health services; cooperative study; human subject; human therapy evaluation; medical outreach /case finding; neoplasm /cancer; neoplasm /cancer therapy; oncology; primary care physician

The objective of the Hawaii Minority-Based Community Clinical Oncology Program (MB-CCOP) is to build on its past several years' success in providing NCI clinical trials to Hawaii cancer patients and high risk individuals in order to reduce cancer incidence, morbidity and mortality by: 1. providing support to expand clinical research in the state of Hawaii, a multi-ethnic population with a majority of ethnic minority cancer patients; 2. bringing the advantages of state-of-the-art treatment and cancer prevention and control research to minority individuals in their own communities; 3. increasing the involvement of primary health care providers and other specialists in cancer treatment, prevention and control studies; 4. facilitating wider participation among underserved populations in NCI-approved research; 5. strengthening the operational base that currently exists to extend cancer prevention and control research in this population. The Cancer Research Center of Hawaii will serve as the administrative headquarters for the MB-CCOP to direct recruitment, accrual, and data management for NCI-approved cancer treatment and control clinical trials. The Southwest Oncology Group, University of Rochester Cancer Center, Gynecologic Oncology Group, Pediatric Oncology Group and the National Surgical Adjuvant Breast and Bowel Project (STAR trial) are the Hawaii MB-CCOP research bases. Participating physicians include all oncologists on the island on Oahu, as well as professionals from other medical and non-medical specialties. All major Oahu hospitals will serve as component institutions. The MB-CCOP will allow the people of Hawaii, about 75 percent of whom are ethnic minorities, to benefit from access to state-of-the-art cancer treatment and control interventions.

夏威夷少数族裔社区临床肿瘤项目（MB-CCOP）的目标是在过去几年为夏威夷癌症患者和高危人群提供NCI临床试验的成功基础上，通过以下方式降低癌症发病率、发病率和死亡率：为扩大夏威夷州的临床研究提供支持，夏威夷州是一个多民族人口的州，少数民族癌症患者占多数；2. 将最先进的治疗和癌症防治研究的优势带给所在社区的少数群体；3. 增加初级保健提供者和其他专家对癌症治疗、预防和控制研究的参与；4. 促进缺医少药人群更广泛地参与nci批准的研究；5. 加强现有的业务基础，在这一人群中扩大癌症预防和控制研究。夏威夷癌症研究中心将作为MB-CCOP的行政总部，指导nci批准的癌症治疗和控制临床试验的招募、累积和数据管理。西南肿瘤学组、罗切斯特大学癌症中心、妇科肿瘤学组、儿科肿瘤学组和国家乳房和肠道手术辅助项目（STAR试验）是夏威夷MB-CCOP研究基地。参与的医生包括瓦胡岛上的所有肿瘤学家，以及其他医疗和非医疗专业的专业人员。所有主要的瓦胡岛医院都将作为组成机构。MB-CCOP将使夏威夷人民（其中约75%是少数民族）受益于最先进的癌症治疗和控制干预措施。